Skip to main content

Jones James's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) · filed Dec 5, 2024

Accession no.
0001628280-24-050111
Filed
Dec 5, 2024
Trade date
Nov 1-29, 2024
Filing delay
34 daysLate
Rule 10b5-1 plan
Checked

This filing lists 20 non-derivative transactions and 0 derivative transactions. Open-market purchases total $1.75K. It was filed 34 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Jones JamesCIK 0001490829Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 1, 2024Common StockPPurchaseAcquired+76$1.15+$87.437,947Direct
Nov 4, 2024Common StockPPurchaseAcquired+49$1.17+$57.3337,996Direct
Nov 5, 2024Common StockPPurchaseAcquired+76$1.20+$91.238,072Direct
Nov 6, 2024Common StockPPurchaseAcquired+76$1.20+$91.238,148Direct
Nov 7, 2024Common StockPPurchaseAcquired+76$1.17+$88.9238,224Direct
Nov 8, 2024Common StockPPurchaseAcquired+76$1.18+$89.6838,300Direct
Nov 11, 2024Common StockPPurchaseAcquired+76$1.20+$91.238,376Direct
Nov 12, 2024Common StockPPurchaseAcquired+76$1.20+$91.238,452Direct
Nov 13, 2024Common StockPPurchaseAcquired+76$1.20+$91.238,528Direct
Nov 14, 2024Common StockPPurchaseAcquired+76$1.19+$90.4438,604Direct
Nov 15, 2024Common StockPPurchaseAcquired+76$1.17+$88.9238,680Direct
Nov 18, 2024Common StockPPurchaseAcquired+76$1.18+$89.6838,756Direct
Nov 19, 2024Common StockPPurchaseAcquired+76$1.15+$87.438,832Direct
Nov 20, 2024Common StockPPurchaseAcquired+85$1.13+$96.0538,917Direct
Nov 21, 2024Common StockPPurchaseAcquired+85$1.09+$92.6539,002Direct
Nov 22, 2024Common StockPPurchaseAcquired+75$1.07+$80.2539,077Direct
Nov 25, 2024Common StockPPurchaseAcquired+75$1.09+$81.7539,152Direct
Nov 26, 2024Common StockPPurchaseAcquired+75$1.11+$83.2539,227Direct
Nov 27, 2024Common StockPPurchaseAcquired+75$1.15+$86.2539,302Direct
Nov 29, 2024Common StockPPurchaseAcquired+75$1.32+$9939,377Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)